-
1
المؤلفون: Irene M, Shui, Emilie, Scherrer, Andrew, Frederickson, Joyce W, Li, Anel, Mynzhassarova, Eric, Druyts, Hussein, Tawbi
المصدر: Melanoma Research. 32:393-404
مصطلحات موضوعية: Cancer Research, Skin Neoplasms, Oncology, Drug Resistance, Neoplasm, Programmed Cell Death 1 Receptor, Humans, Immunotherapy, Dermatology, Ipilimumab, Melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24277db8ff02d4b150d4a28e6f90efe7Test
https://doi.org/10.1097/cmr.0000000000000850Test -
2
المؤلفون: Xiang-Lin Tan, Amy Le, Huilin Tang, Madeline Brown, Emilie Scherrer, Jiali Han, Ruixuan Jiang, Scott J. Diede, Irene M. Shui
المصدر: Cancers. 14(24)
مصطلحات موضوعية: Cancer Research, Oncology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb290ffe2438d1d74434f3522a37a1fTest
https://pubmed.ncbi.nlm.nih.gov/36551594Test -
3
المؤلفون: Wolfram Samlowski, Michelle A Silver, Andriana Hohlbauch, Shujing Zhang, Emilie Scherrer, Mizuho Fukunaga-Kalabis, Clemens Krepler, Ruixuan Jiang
المصدر: Future oncology (London, England).
مصطلحات موضوعية: Cancer Research, Oncology, General Medicine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff745c8c14b0d9390ca5e120b16b5169Test
https://pubmed.ncbi.nlm.nih.gov/36346064Test -
4
المؤلفون: Wen-Xi, Tang, Rong-Jie, Shao, Jingshu, Wang, Emilie, Scherrer, Ai-Xia, Ma, Raquel, Aguiar-Ibáñez
المصدر: Value in Health Regional Issues. 27:99-107
مصطلحات موضوعية: Paclitaxel, Cost-Benefit Analysis, Health Policy, Economics, Econometrics and Finance (miscellaneous), Humans, Antibodies, Monoclonal, Humanized, Melanoma, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Carboplatin
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae422b816fc14914ad74a0af85da7dcTest
https://doi.org/10.1016/j.vhri.2021.04.007Test -
5
المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano
المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test -
6
المؤلفون: Emilie Scherrer, Ashley Kang, Lisa M. Bloudek, Vadim S. Koshkin
المصدر: Frontiers in Oncology. 12
مصطلحات موضوعية: Cancer Research, Oncology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0b23064496ab155ac25d86ba7a7e3351Test
https://doi.org/10.3389/fonc.2022.1011885Test -
7
المؤلفون: Xiang-Lin, Tan, Amy, Le, Fred C, Lam, Emilie, Scherrer, Robert G, Kerr, Anthony C, Lau, Jiali, Han, Ruixuan, Jiang, Scott J, Diede, Irene M, Shui
المصدر: Frontiers in Oncology. 12
مصطلحات موضوعية: Cancer Research, Oncology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b976ff6ff90e538675ab5a3f8015cffTest
https://doi.org/10.3389/fonc.2022.885472Test -
8
المؤلفون: Vadim S Koshkin, Christine Boyiddle, Naomi Schwartz, Judy Yu, Kristina S. Yu, Ashley Kang, Lisa Bloudek, Qijun Fang, Johanna M. Schafer, Amanda F. Baker, Farzaneh H. Sayedian, Emilie Scherrer
المصدر: Journal of Clinical Oncology. 41:556-556
مصطلحات موضوعية: Cancer Research, Oncology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9bcf268cca6be335992285c8e3a531b6Test
https://doi.org/10.1200/jco.2023.41.6_suppl.556Test -
9
المؤلفون: Victoria Wurcel, Juan Ignacio Altuna, Fernando Carabajal, Gargi Baluni, Raquel Aguiar-Ibáñez, Shrishti Jain, Emilie Scherrer
المصدر: Oncology and Therapy
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Cost effectiveness, Melanoma, medicine.medical_treatment, Hazard ratio, Argentina, Pembrolizumab, Adjuvant treatment, medicine.disease, Confidence interval, Latin America, Internal medicine, Medicine, Cost-effectiveness, Stage (cooking), business, health care economics and organizations, Reimbursement, Watchful waiting, Original Research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ffa07f0b556a00966d5479d4441a82Test
https://doi.org/10.1007/s40487-021-00142-8Test -
10
المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar
المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicineمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test